WaferGen Bio Profile

6.90
USD 0.00  0.00%
0%

WaferGen Bio exotic insider transaction detected

WaferGen Bio systems insider trading alert for general transaction of stock option (right to buy) by Joseph Victor, CTO, on April 18, 2018. This event was filed by Wafergen Biosystems Inc with SEC on 2008-10-06. Initial filing of beneficial ownership - SEC Form 3 [view details]   

WaferGen Bio Summary

WaferGen Bio systems (WGBS) is traded on Nasdaq Capital Markets in USA. It is located in CALIFORNIA, U.S.A and employs 55 people. WaferGen Bio is listed under Measuring and Control Equipment category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 26.22 M. WaferGen Bio systems has 3.8 M outstanding shares of which 240.41 K shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. WAFERGEN BIO-SYST currently holds about 5.15 M in cash with (13.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check WaferGen Bio Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
close to 99%30 days 6.90  near 1%
Based on normal probability distribution, the odds of WaferGen Bio to move above current price in 30 days from now is near 1% (This WaferGen Bio systems probability density function shows the probability of WaferGen Bio Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Sabby Management Llc 0Common Shares358.5 K1.8 M
Opaleye Management IncCommon Shares320 K1.6 M
View WaferGen Bio Diagnostics

Key Fundamentals

WaferGen Bio Against Markets

Current Ratings

WaferGen Bio 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 91% 
Equity ratings for WaferGen Bio systems are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. more
Fama & French Measuring and Control Equipment
Measuring and Control Equipment
Fama & French Classification
NameWaferGen Bio systems
CEO and President and DirectorRolland CarlsonView All
Thematic Classification
Currently Active Investing Idea
  Measuring and Control Equipment
View All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
LocationCALIFORNIA, U.S.A
Business AddressWaferGen Biosystems, Inc.Fremont, CA
ExchangeNasdaq Capital Markets
CUSIP93041P308
IndustryMeasuring and Control Equipment
BenchmarkDOW
Websitewww.wafergen.com
Contact Number510 651 4450
CurrencyUSD - US Dollar

Recommendations

WaferGen Bio Analyst Recommendations
Target PriceAdvice# of Analysts
1.5Strong Buy1Odds
WaferGen Bio systems current and past analyst recommendations published by number of research institutions as well as average analyst consensus
WaferGen Bio Analyst Advice  

Directors

WaferGen Bio Corporate Directors
Makoto Kaneshiro Independent Director, MBA
Robert Schueren Director
Joel Kanter Lead Independent Director
See also Your Current Watchlist. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.